EU Regulatory Round-Up: RWE Platform Proposed, Brexit Transition Update, EPI Principles Published
The latest EU regulatory developments - EMA and HMA are looking to build an EU-wide real-world data platform; EU OTC firms can operate as normal in the UK until the end of the year; EMA, HMA and the EC have published key principles on how to develop and use electronic product information for medicines marketed within the EU.
You may also be interested in...
HBWI Exclusive: As the coronavirus pandemic worsens across Europe, the region's wholesalers work at full capacity to keep up with demand for OTC products.
Breaking News: The European Medicines Agency says there is no evidence that ibuprofen worsens Covid‑19 and that consumers can carry on using the drug as advised by patient information.
In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines, food supplements and self-care medical devices, according to the AESGP.